Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
ProQR Unveils Preclinical Proof of Concept Findings for AX-0810 Axiomer™ RNA Editing Initiative Targeting NTCP in Combatting Cholestatic Conditions
Thursday, May 09, 2024ProQR Therapeutics NV revealed significant preclinical findings at the American Society of Gene Cell Therapy Annual Meeting in Baltimore Maryland Their proprietary Axiomer RNA editing
CytomX Therapeutics Shares Positive Phase 1a Dose Escalation Findings for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)
Thursday, May 09, 2024CytomX Therapeutics Inc announced positive initial findings from the ongoing CX Phase a dose escalation clinical study The study focuses on CX a novel masked conditionally activated PROBODY
NSG BioLabs Drives Biotech Innovation in Singapore and Southeast Asia through EnterpriseSG and Merck Collaborations, Supported by Investments from Celadon Partners and ClavystBio
Wednesday, May 08, 2024NSG BioLabs a prominent provider of biotech coworking laboratory and office spaces in Singapore
BioVersys Expands Collaboration with GSK and Boosts Series C Funding by CHF 12.3 Million
Wednesday, May 08, 2024BioVersys AG a clinicalstage biopharmaceutical company and GSK plc a global biopharma leader have announced an expansion of their strategic collaboration
VYNE Therapeutics Receives FDA Clearance for IND Application of VYN202, a Unique BD2-Selective BET Inhibitor
Tuesday, May 07, 2024VYNE Therapeutics Inc announced today that the US Food and Drug Administration has cleared its Investigational New Drug application for VYN an oral BDselective BET inhibitor
BioAtla Receives FDA Clearance for Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate Targeting Multiple Tumors
Tuesday, May 07, 2024BioAtla Inc has received clearance from the US Food and Drug Administration to proceed with its investigational new drug application for BA an antibodydrug conjugate
Adcentrx Therapeutics Receives IND Clearance from China NMPA for ADRX-0706, a Novel Nectin-4 ADC Aimed at Advanced Solid Tumors
Tuesday, May 07, 2024Adcentrx Therapeutics a prominent biotechnology firm specializing in advancing AntibodyDrug Conjugate therapies for cancer and other severe illnesses has shared significant news They announced that the China
Calliditas Announces Positive Topline Results from Phase 2 Trial of Setanaxib, its Lead NOX Inhibitor Candidate, in Head and Neck Cancer
Monday, May 06, 2024Calliditas Therapeutics AB has unveiled significant findings from its Phase trial investigating setanaxib its primary NOX enzyme inhibitor in combination
Discovery of a Lesser-Known Choline Transporter in the Brain Highlights Potential Therapeutic Avenue for Age-Related Cognitive Decline and Alzheimer's Disease
Monday, May 06, 2024Researchers at the Yong Loo Lin School of Medicine at the National University of Singapore have made an intriguing discovery regarding the orphan transporter known as Mfsdc at the bloodbrain barrier
ImmunityBio and Serum Institute of India Reach Exclusive Agreement for Global BCG Supply in Treating All Cancer Types
Friday, May 03, 2024ImmunityBio Inc recently announced an exclusive global collaboration with the Serum Institute of India the worlds largest vaccine manufacturer in terms of doses produced This partnership
